AR056839A1 - Metodos para la administracion transdermica de un agonista indol del receptor de serotonina y composiciones transdermicas para usar en los mismos - Google Patents
Metodos para la administracion transdermica de un agonista indol del receptor de serotonina y composiciones transdermicas para usar en los mismosInfo
- Publication number
- AR056839A1 AR056839A1 ARP060105393A ARP060105393A AR056839A1 AR 056839 A1 AR056839 A1 AR 056839A1 AR P060105393 A ARP060105393 A AR P060105393A AR P060105393 A ARP060105393 A AR P060105393A AR 056839 A1 AR056839 A1 AR 056839A1
- Authority
- AR
- Argentina
- Prior art keywords
- transdermal
- receptor agonist
- methods
- indolor
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Métodos para la administracion transdérmica de una cantidad terapéutica de un agonista indol del receptor de serotonina a un individuo que lo necesita, por ejemplo, para conferir un nivel terapéutico de un agonista indol del receptor de serotonina a un individuo que lo necesita. También se presentan formulaciones transdérmicas de agonistas indol del receptor de serotonina que son de utilidad en la práctica de los presentes métodos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75276705P | 2005-12-20 | 2005-12-20 | |
US79045106P | 2006-04-06 | 2006-04-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR056839A1 true AR056839A1 (es) | 2007-10-24 |
Family
ID=38371959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105393A AR056839A1 (es) | 2005-12-20 | 2006-12-06 | Metodos para la administracion transdermica de un agonista indol del receptor de serotonina y composiciones transdermicas para usar en los mismos |
Country Status (13)
Country | Link |
---|---|
US (2) | US7816394B2 (es) |
EP (1) | EP1962837A4 (es) |
JP (2) | JP5225100B2 (es) |
KR (1) | KR20080077998A (es) |
AR (1) | AR056839A1 (es) |
AU (2) | AU2006338165B2 (es) |
BR (1) | BRPI0620216A2 (es) |
CA (1) | CA2633588A1 (es) |
EA (1) | EA200801369A1 (es) |
IL (1) | IL192074A0 (es) |
MX (1) | MX2008007897A (es) |
TW (1) | TW200738288A (es) |
WO (1) | WO2007094876A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100209484A1 (en) * | 2009-02-13 | 2010-08-19 | Hoo-Kyun Choi | Transdermal Triptan Delivery System |
EP2338873A1 (en) | 2009-12-22 | 2011-06-29 | Gmeiner, Peter | New aminotetraline derivatives |
US9557878B2 (en) * | 2012-04-25 | 2017-01-31 | International Business Machines Corporation | Permitting participant configurable view selection within a screen sharing session |
US9505737B2 (en) | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
EP3712142B1 (en) | 2013-01-11 | 2022-07-06 | Corsair Pharma, Inc. | Prodrugs of treprostinil |
JP6002055B2 (ja) * | 2013-02-13 | 2016-10-05 | 久光製薬株式会社 | 貼付剤 |
JP6151935B2 (ja) * | 2013-03-11 | 2017-06-21 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
JP6216151B2 (ja) * | 2013-04-19 | 2017-10-18 | コスメディ製薬株式会社 | 親水性薬物のエマルジョンパッチ |
US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
US9394227B1 (en) | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
TW202016088A (zh) | 2018-06-19 | 2020-05-01 | 德商Ucb製藥有限公司 | 吡啶基及吡基-(氮)吲哚磺醯胺 |
EP3584244A1 (en) | 2018-06-20 | 2019-12-25 | UCB Pharma GmbH | Substituted alkoxypyridinyl indolsulfonamides |
CN113993845A (zh) | 2019-06-17 | 2022-01-28 | 优时比制药有限公司 | 作为治疗cns障碍例如多发性硬化的gpr17调节剂的n-(苯基)-吲哚-3-磺酰胺衍生物和相关化合物 |
AU2021268204A1 (en) | 2020-05-08 | 2022-12-08 | Psilera Inc. | Novel compositions of matter and pharmaceutical compositions |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4314976C1 (de) * | 1993-05-06 | 1994-10-06 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung |
US5807571A (en) * | 1993-05-06 | 1998-09-15 | Lts Lohmann Therapie-Systeme Gmbh | Transdermal therapeutic systems for administering indole serotonin agonists |
JPH08319234A (ja) * | 1995-05-24 | 1996-12-03 | Yuutoku Yakuhin Kogyo Kk | 経皮吸収型消炎鎮痛貼付剤 |
DE19738855C2 (de) * | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht |
US6955819B2 (en) * | 1998-09-29 | 2005-10-18 | Zars, Inc. | Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances |
US20050042271A1 (en) * | 1999-11-19 | 2005-02-24 | Xel Herbaceuticals, Inc . | Transdermal delivery system for alkaloids of aconitum species |
DE19959913A1 (de) * | 1999-12-11 | 2001-06-28 | Lohmann Therapie Syst Lts | Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne |
US6579878B1 (en) * | 2000-07-07 | 2003-06-17 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
US6579898B2 (en) | 2001-03-01 | 2003-06-17 | Pfizer Inc. | Compositions having improved bioavailability |
ES2559666T3 (es) | 2001-03-07 | 2016-02-15 | Hisamitsu Pharmaceutical Co., Inc. | Parche adhesivo |
DK1435945T3 (da) * | 2001-06-05 | 2008-12-01 | Ronald Aung-Din | Topisk migræne terapi |
JP2003129022A (ja) * | 2001-08-10 | 2003-05-08 | Kosumedei:Kk | 皮膚用粘着テープ |
JP4792193B2 (ja) * | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | 貼付剤 |
JP2004292379A (ja) * | 2003-03-27 | 2004-10-21 | Nichiban Co Ltd | 貼付剤 |
US20040258740A1 (en) * | 2003-04-10 | 2004-12-23 | Nene Labs | Transdermal delivery composition |
US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
-
2006
- 2006-11-17 AU AU2006338165A patent/AU2006338165B2/en not_active Ceased
- 2006-11-17 MX MX2008007897A patent/MX2008007897A/es unknown
- 2006-11-17 KR KR1020087014956A patent/KR20080077998A/ko not_active Application Discontinuation
- 2006-11-17 BR BRPI0620216-0A patent/BRPI0620216A2/pt not_active IP Right Cessation
- 2006-11-17 WO PCT/US2006/061049 patent/WO2007094876A2/en active Application Filing
- 2006-11-17 EA EA200801369A patent/EA200801369A1/ru unknown
- 2006-11-17 EP EP20060850169 patent/EP1962837A4/en not_active Ceased
- 2006-11-17 JP JP2008547672A patent/JP5225100B2/ja not_active Expired - Fee Related
- 2006-11-17 US US11/561,235 patent/US7816394B2/en not_active Expired - Fee Related
- 2006-11-17 CA CA002633588A patent/CA2633588A1/en not_active Abandoned
- 2006-11-29 TW TW095144059A patent/TW200738288A/zh unknown
- 2006-12-06 AR ARP060105393A patent/AR056839A1/es not_active Application Discontinuation
-
2008
- 2008-06-11 IL IL192074A patent/IL192074A0/en unknown
-
2010
- 2010-09-08 US US12/877,848 patent/US8609134B2/en not_active Expired - Fee Related
- 2010-11-04 AU AU2010241230A patent/AU2010241230A1/en not_active Abandoned
-
2012
- 2012-11-12 JP JP2012248357A patent/JP2013063992A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EA200801369A1 (ru) | 2009-02-27 |
US20070140977A1 (en) | 2007-06-21 |
US7816394B2 (en) | 2010-10-19 |
WO2007094876A2 (en) | 2007-08-23 |
IL192074A0 (en) | 2009-02-11 |
JP2009520830A (ja) | 2009-05-28 |
US20110002967A1 (en) | 2011-01-06 |
BRPI0620216A2 (pt) | 2011-11-01 |
JP5225100B2 (ja) | 2013-07-03 |
AU2010241230A1 (en) | 2010-11-25 |
EP1962837A2 (en) | 2008-09-03 |
JP2013063992A (ja) | 2013-04-11 |
EP1962837A4 (en) | 2011-12-14 |
AU2006338165A1 (en) | 2007-08-23 |
MX2008007897A (es) | 2009-03-04 |
CA2633588A1 (en) | 2007-08-23 |
TW200738288A (en) | 2007-10-16 |
US8609134B2 (en) | 2013-12-17 |
WO2007094876A3 (en) | 2008-10-16 |
AU2006338165B2 (en) | 2010-10-28 |
KR20080077998A (ko) | 2008-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR056839A1 (es) | Metodos para la administracion transdermica de un agonista indol del receptor de serotonina y composiciones transdermicas para usar en los mismos | |
CY1122812T1 (el) | Δοσολογικο σχημα για εναν αγωνιστη του υποδοχεα s1p | |
AR055123A1 (es) | Asociacion de un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion corta, composicion farmaceutica que la contiene y su aplicacin en terapeutica | |
CL2009000161A1 (es) | Compuestos derivados de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol; composicion farmaceutica que los comprende; uso en el tratamiento de trastornos neurodegenerativos, cognitivos o psicoticos, enfermedad de alzheimer, entre otros; y un kit que contiene a los compuestos. | |
HN2006007884A (es) | Derivados de oxiindol | |
AR043987A1 (es) | Composiciones farmaceuticas para administracion oral de agonistas del receptor de fosfato de esfingosina-1 | |
ECSP088222A (es) | Agonistas de receptores adrenérgicos alfa2c funcionalmente selectivos | |
CL2008002539A1 (es) | Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral | |
UY31436A1 (es) | Nuevos compuestos tetracíclicos | |
CU20130009A7 (es) | Compuestos heterociclícos agonistas del receptor ip | |
UY28766A1 (es) | Compuestos heteropolicíclicos adicionales y su uso como antagonistas del receptor de glutamato metabotrópico | |
CL2011000835A1 (es) | Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras. | |
CY1112724T1 (el) | Παραγωγα ανθρακικης κουινουκλιδινης και ιατρικη συνθεση αυτων | |
CL2008002864A1 (es) | Compuestos derivados de 2-amino-quinolina, antagonistas del receptor de serotonina 5-ht 5a; procedimiento de preparacion;composicion farmaceutica; y uso de los compuestos en la prevencion o el tratamiento de depresion,trastornos de ansiedad,esquizofrenia,trastornos de panico,trastornos de memoria,demencia,entre otros. | |
ECSP088221A (es) | Agonistas adrenoreceptores alfa2c | |
EA201001256A1 (ru) | Производные диазаспиро[5.5]ундекана в качестве антагонистов мускариновых рецепторов и агонистов бета-адренорецепторов для применения в лечении легочных расстройств | |
CR11264A (es) | Compuestos de 5-(4-halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones como inhibidores de cinasa | |
NI201100085A (es) | Antagonistas de los receptores tipo toll 3 | |
CL2011000148A1 (es) | Compuestos derivados de piperidina puenteada tipo quinoxalina, de accion moduladora del receptor orl-1; composicion farmaceutica que los comrende; procedimiento de preparacion de la composicion; kit farmaceutico; y uso de los compuestos para el tratamiento del dolor. | |
CL2008001321A1 (es) | Compuestos derivados de (cromanil o tiocromanil o naftalenil)-1,3-dihidroimidazol-2-tiona, inhibodores de dopamina betahidroxilasa; procedimiento de preparacion de enantiomeros (r) y (s) separados o en mezcla; composicion farmaceutica; y su uso en el tratamiento de ansiedad, jaqueca, trastornos cardiovasculares, entre otros. | |
CL2012001352A1 (es) | Compuestos heterocíclicos derivados de amina, moduladores del receptor s1p; composición farmacéutica que los comprende; uso para tratar enfermedades oculares, vasculares sistémicas inflamatorias, autoinmunitarias e inmunosupresión, cicatrización y dolor entre otras. | |
CR11584A (es) | Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina | |
CO6300937A2 (es) | Derivados de 3-carboxipropil-aminotetralina y compuestos relacionados como antagonistas de receptores opioides mu | |
MX2009010424A (es) | Formulaciones de dosificacion oral de agonista del receptor de serotina de indol organolepticamente aceptable y metodos para utilizar las mismas. | |
NO20073501L (no) | Pyrrolidin-2-on derivater for anvendelse som DPI reseptor agonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |